Showing results (421-430 of 463) with videos related to

Sort By:
Pageof 47
Journal of Autoimmunity|September 3, 2015
Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study GroupGonzalo de Luna, Dominique Chauveau, Julien Aniort, et al.
Clinical & Translational Immunology|September 17, 2021
Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritisMaxime Samson, Hélène Greigert, Marion Ciudad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2025
ANCA-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap with Significant Implications for Treatment and OutcomesDeborah Eshagh, Thomas Quéméneur, Alexandre Karras, et al.
Science (New York, N.Y.)|July 13, 2013
Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2DBenjamin Chaigne-Delalande, Feng-Yen Li, Geraldine M O'Connor, et al.
Rheumatology (Oxford, England)|February 27, 2023
Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomesBoris Sorin, Michele Iudici, Mary-Jane Guerry, et al.
Arthritis Care & Research|December 5, 2020
Osteitis in Systemic Sclerosis: A Nationwide Case-Control Retrospective StudyCyril Cosse, Solen Kernéis, Alain Lescoat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2017
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled TrialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.
Rheumatology (Oxford, England)|March 20, 2019
Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patientsCécile-Audrey Durel, Arnaud Hot, Ludovic Trefond, et al.
Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.
Pageof 47